LeMaitre Vascular, Inc.
General ticker "LMAT" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $2.2B (TTM average)
LeMaitre Vascular, Inc. does not follow the US Stock Market performance with the rate: -7.7%.
Estimated limits based on current volatility of 1.7%: low 81.42$, high 84.29$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-08-20, amount 0.25$ (Y1.24%)
- Total employees count: 655 (-1.4%) as of 2025
- US accounted for 56.7% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Maintain historical profit growth, Market competition, Acquisition/divestiture risks, Geopolitical risks, Supply chain disruptions
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [71.10$, 103.63$]
- 2026-12-31 to 2027-12-31 estimated range: [75.60$, 109.16$]
Financial Metrics affecting the LMAT estimates:
- Positive: with PPE of 35.0 at the end of fiscal year the price was neutral
- Positive: 22.58 < Operating profit margin, % of 27.21
- Positive: 2.37 < Operating cash flow per share per price, % of 4.30
- Positive: Interest expense per share per price, % of 0.27 <= 0.33
- Positive: 58.56 < Shareholder equity ratio, % of 63.91 <= 69.38
- Positive: 0.90 < Industry operating cash flow per share per price (median), % of 1.58
- Positive: -4.49 < Investing cash flow per share per price, % of -3.44
- Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 8.57
- Positive: -16.84 < Industry operating profit margin (median), % of -7.42
Short-term LMAT quotes
Long-term LMAT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $193.48MM | $219.86MM | $249.60MM |
| Operating Expenses | $156.77MM | $167.61MM | $181.69MM |
| Operating Income | $36.71MM | $52.26MM | $67.91MM |
| Non-Operating Income | $2.76MM | $4.62MM | $7.27MM |
| Interest Expense | $0.00MM | $0.20MM | $5.18MM |
| R&D Expense | $16.97MM | $15.65MM | $14.14MM |
| Income(Loss) | $39.48MM | $56.88MM | $75.18MM |
| Taxes | $9.37MM | $12.84MM | $17.45MM |
| Net Income(Loss)* | $30.11MM | $44.04MM | $57.73MM |
| Stockholders Equity | $297.90MM | $337.29MM | $393.52MM |
| Inventory | $52.33MM | $55.94MM | $70.42MM |
| Assets | $346.78MM | $551.82MM | $615.69MM |
| Operating Cash Flow | $36.75MM | $44.12MM | $81.25MM |
| Capital expenditure | $7.26MM | $6.96MM | $6.78MM |
| Investing Cash Flow | $-24.71MM | $-200.12MM | $-64.94MM |
| Financing Cash Flow | $-7.13MM | $158.10MM | $-14.54MM |
| Earnings Per Share** | $1.36 | $1.96 | $2.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.